业务出售

Search documents
消息人士称,索尼正在探索出售蜂窝芯片组业务
news flash· 2025-07-23 16:29
Core Viewpoint - Sony Group is exploring the sale of its cellular chipset business to focus more on the entertainment sector [1] Group 1: Business Overview - The cellular chipset division generates approximately $80 million in recurring revenue annually [1] - The estimated valuation for the sale of this business is around $300 million [1] Group 2: Market Interest - The potential sale is expected to attract interest from financial sponsors and participants in the semiconductor industry [1]
Walgreens Reports Narrower Than Expected Loss Ahead Of Takeover
Forbes· 2025-06-26 11:45
Core Viewpoint - Walgreens Boots Alliance reported a narrower-than-expected loss of $175 million in its third quarter, as the company approaches the end of its tenure as a publicly traded entity [2][3]. Financial Performance - For the fiscal third quarter ending May 31, Walgreens experienced a 7% increase in sales, reaching $39 billion, despite a loss of $175 million, which is a decrease of $519 million compared to net earnings of $344 million in the same period last year [3]. - The U.S. Retail Pharmacy segment sales rose nearly 8% to $39.7 billion compared to the previous year, although retail sales within that segment decreased by 5%, leading to a 30% drop in adjusted operating income to $350 million from $501 million [5]. Strategic Developments - Walgreens is in the process of completing a sale to Sycamore Partners for over $10 billion, with a special shareholder meeting scheduled for July 11 to vote on the deal [3][4]. - The Sycamore deal includes a payment of $11.45 per share, which is 29% above the stock price from December [4]. - The total value of the Sycamore deal exceeds $23 billion when including debt and other items [7]. Operational Challenges - The company has faced significant challenges, including a disastrous rollout of in-store clinics, leading to numerous pharmacy closures and a decline in stock value [4][9]. - Walgreens has lost more than $3.2 billion, or $3.81 per share, for the nine-month period ending May 31, compared to a loss of $5.6 billion, or $6.53 per share, in the previous year [10]. Future Outlook - The CEO emphasized the need for a turnaround plan that requires time and a balanced approach to manage future cash needs while making necessary investments [6].
星巴克否认完全出售中国业务
日经中文网· 2025-06-25 03:13
Core Viewpoint - Starbucks is exploring ways to maximize growth opportunities in the Chinese market, which is considered to have significant long-term potential, despite recent challenges from local competitors and economic slowdown [1][2]. Group 1: Market Position and Strategy - China is Starbucks' second-largest market after the United States, highlighting its importance to the company's global strategy [1][2]. - The company has denied reports of a complete sale of its Chinese operations but is considering selling parts of its business as it seeks the best path for growth [2]. Group 2: Competitive Landscape - Starbucks faces increasing competition from local brands such as Luckin Coffee and Mixue Ice Cream, which has intensified price competition in the market [2]. - In response to local competition, Starbucks implemented its first price reduction in China, lowering the average price of several drinks, including iced tea and Frappuccino, by approximately 5 yuan [2].
将向高瓴资本等出售业务?星巴克中国回应:没有考虑完全出售
Nan Fang Du Shi Bao· 2025-06-24 08:19
Core Viewpoint - Starbucks China is exploring options for its business, including a potential sale, with an estimated valuation of $5 billion to $6 billion, while emphasizing its commitment to growth in the Chinese market [2][3]. Group 1: Business Sale Exploration - Starbucks China held a meeting with nearly 20 investment institutions, including Hillhouse Capital and Carlyle Group, to discuss the potential sale of its business [2]. - The company is currently evaluating the best ways to capture future growth opportunities and has confirmed that it is not considering a complete sale of its Chinese operations [2]. - Previous reports indicated that Starbucks has been exploring various options for its Chinese business since last year, including the possibility of selling a stake and seeking local partners [3]. Group 2: Financial Performance - For the fiscal year 2024, Starbucks China reported revenues of $2.968 billion, approximately 21.544 billion RMB, a decrease of 6.13% compared to the previous year [4]. - In the first quarter of fiscal year 2025, revenues increased by 1.22% to $744 million, while same-store sales declined by 6% [4]. - The second quarter of fiscal year 2025 saw a revenue increase of 4.80% to $740 million, with same-store sales remaining flat despite a 4% increase in transaction volume [4]. Group 3: Pricing Strategy and Market Position - In June, Starbucks China announced a focus on non-coffee beverages and initiated a price reduction across several drink categories, marking the first official price cut in 25 years [5]. - The average price reduction for drinks is approximately 5 RMB, with the lowest price for a single drink set at 23 RMB [5]. - Since 2023, Starbucks China has experienced continuous price reductions for 10 consecutive fiscal quarters, with average customer spending decreasing by 9%, 8%, 7%, and 8% in the first to fourth quarters of fiscal year 2024 [5].
滉达富控股(01348)拟1120万港元出售Crosby Asia全部已发行股本及待售贷款
智通财经网· 2025-06-08 11:12
Group 1 - The company has entered into an agreement with Emperor Securities Investment Holdings Limited to sell all issued shares and loans of Crosby Asia for an estimated price of approximately HKD 11.2 million [1] - Following the completion of the sale, Crosby Asia and its subsidiaries will no longer be part of the company's consolidated financial statements, which will help streamline operations and reduce financial burdens [1][2] - The decision to sell Crosby Asia is driven by its continuous losses and the need for significant capital injection to restore profitability, particularly in light of increased operational costs and regulatory capital requirements [2] Group 2 - The estimated net proceeds from the sale are expected to be around HKD 10.9 million, which will provide additional working capital to strengthen the company's financial position [2] - The sale is seen as a strategic move to alleviate high operational costs associated with Crosby Asia, allowing the company to reallocate financial resources more effectively [2] - The company aims to enhance its financial resilience, especially considering challenges posed by the US-China trade war, which has impacted the toy division [2]
超230亿元!化工并购,1天2起
Zhong Guo Hua Gong Bao· 2025-05-26 02:11
Group 1: Johnson Matthey's Catalyst Technology Business Sale - Johnson Matthey announced the sale of its catalyst technology business to Honeywell for £1.8 billion (approximately RMB 17.4 billion), expected to complete in the first half of 2026 [2] - The catalyst technology business is a leader in the synthesis gas sector and has a strong sustainable technology portfolio, which will provide Johnson Matthey with £1.6 billion in cash [2] - Post-sale, Johnson Matthey will be restructured to focus on clean air and platinum group metals services [2][3] Group 2: Honeywell's Acquisition - Honeywell stated that the acquisition complements its UOP business and expands its capabilities in refining and petrochemical catalysts [2] - The expanded product portfolio will enable Honeywell to offer comprehensive solutions for producing low-emission fuels, including sustainable methanol and sustainable aviation fuel [2] Group 3: Goodyear's Chemical Business Sale - Goodyear Tire & Rubber Company announced the sale of most of its chemical business to Gemspring Capital for approximately $650 million (around RMB 6.3 billion), expected to close by the end of 2025 [4] - The transaction includes Goodyear's chemical plants in Houston and Beaumont, Texas, and related research offices in Akron, Ohio, along with a long-term supply agreement [4] - Goodyear's CEO emphasized the commitment to optimizing the portfolio and creating shareholder value through this sale [4]
153亿!净利润下降89%!新医械巨头断腕自救?
思宇MedTech· 2025-03-05 03:51
合作伙伴征集:2025全球手术机器人大会 报名:首届全球眼科大会 | 展位有限 报名:首届全球心血管大会 | 奖项评选 报名:首届全球骨科大会 | 奖项评选 2025年2月28日,尽管第四季度业绩超出华尔街的共识预期,Solventum(纽交所代码:SOLV)的股价仍出现下跌。截至28日下午交易时段,SOLV股价 下跌超过 4% ,至每股 79.17美元 。 Solventum在销售额增长 1.9% 的情况下,净利润却大幅下滑了 89% 。调整后,剔除一次性项目,每股收益为 1.41美元 ,比华尔街预期高出10美分。销 售额略高于预期,专家此前预测的收入为20.5亿美元。 # 财 报 详情 第四季度财务摘要 净销售额为 21亿 美元(约合153亿人民币),同比增长 1.9% ,有机销售额增长2.3%。 调整后每股收益(EPS)为 1.41美元 ,运营利润率为20.4%。 自由现金流(FCF)为 9200万 美元。 2024年财务摘要 净销售额为 83亿美元 ,同比增长 0.7% ,有机销售额增长1.2%。 调整后每股收益(EPS)为 6.70 美元,运营利润率为22.0%。 自由现金流(FCF)为 8.05亿 ...